Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cell Tracking | 2 | 2021 | 145 | 0.880 |
Why?
|
Hyper-IgM Immunodeficiency Syndrome, Type 1 | 1 | 2021 | 3 | 0.790 |
Why?
|
Hyper-IgM Immunodeficiency Syndrome | 1 | 2021 | 9 | 0.790 |
Why?
|
Hematopoietic Stem Cells | 11 | 2024 | 3381 | 0.790 |
Why?
|
Clone Cells | 2 | 2021 | 1692 | 0.640 |
Why?
|
Epitopes | 2 | 2023 | 2569 | 0.630 |
Why?
|
Gene Targeting | 4 | 2017 | 880 | 0.520 |
Why?
|
Targeted Gene Repair | 1 | 2014 | 20 | 0.490 |
Why?
|
X-Linked Combined Immunodeficiency Diseases | 1 | 2014 | 23 | 0.490 |
Why?
|
Antigens, CD34 | 4 | 2023 | 657 | 0.480 |
Why?
|
Lentivirus | 5 | 2018 | 501 | 0.380 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2023 | 3497 | 0.340 |
Why?
|
Immunotherapy | 1 | 2023 | 4414 | 0.310 |
Why?
|
Software | 1 | 2021 | 4434 | 0.290 |
Why?
|
Natural Killer T-Cells | 2 | 2024 | 315 | 0.290 |
Why?
|
Fanconi Anemia Complementation Group A Protein | 2 | 2017 | 46 | 0.280 |
Why?
|
Zinc Fingers | 3 | 2012 | 585 | 0.240 |
Why?
|
T-Lymphocytes | 5 | 2023 | 10163 | 0.240 |
Why?
|
Hematopoietic Stem Cell Transplantation | 5 | 2024 | 5425 | 0.240 |
Why?
|
Receptors, Antigen, T-Cell | 4 | 2024 | 2524 | 0.230 |
Why?
|
Fanconi Anemia | 2 | 2017 | 319 | 0.230 |
Why?
|
Epitope Mapping | 1 | 2023 | 311 | 0.210 |
Why?
|
Hematopoiesis | 3 | 2023 | 2066 | 0.190 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2023 | 3557 | 0.190 |
Why?
|
Genome, Human | 1 | 2014 | 4420 | 0.190 |
Why?
|
Genetic Vectors | 5 | 2021 | 3420 | 0.190 |
Why?
|
Tumor Escape | 1 | 2023 | 349 | 0.190 |
Why?
|
DNA Barcoding, Taxonomic | 1 | 2021 | 136 | 0.180 |
Why?
|
Interleukin Receptor Common gamma Subunit | 3 | 2017 | 88 | 0.180 |
Why?
|
Deoxyribonucleases, Type II Site-Specific | 2 | 2012 | 170 | 0.180 |
Why?
|
Multiple Myeloma | 3 | 2024 | 5169 | 0.140 |
Why?
|
Transplantation Conditioning | 1 | 2023 | 1597 | 0.140 |
Why?
|
Lymphocyte Activation | 3 | 2024 | 5519 | 0.140 |
Why?
|
DNA, Complementary | 2 | 2022 | 2049 | 0.140 |
Why?
|
Cyclosporine | 1 | 2018 | 784 | 0.130 |
Why?
|
T-Cell Antigen Receptor Specificity | 2 | 2013 | 87 | 0.130 |
Why?
|
Transduction, Genetic | 1 | 2018 | 913 | 0.130 |
Why?
|
Bone Marrow Transplantation | 1 | 2023 | 2763 | 0.130 |
Why?
|
Gene Transfer Techniques | 4 | 2017 | 1224 | 0.120 |
Why?
|
Adoptive Transfer | 1 | 2017 | 844 | 0.120 |
Why?
|
Mice | 13 | 2024 | 81045 | 0.120 |
Why?
|
Antigens, Neoplasm | 3 | 2024 | 1983 | 0.120 |
Why?
|
B-Lymphocyte Subsets | 1 | 2015 | 246 | 0.120 |
Why?
|
Animals | 14 | 2024 | 168561 | 0.110 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2020 | 2948 | 0.100 |
Why?
|
Mesenchymal Stem Cells | 1 | 2022 | 1625 | 0.100 |
Why?
|
Fetal Blood | 2 | 2017 | 1317 | 0.100 |
Why?
|
Recurrence | 1 | 2023 | 8333 | 0.100 |
Why?
|
Endonucleases | 1 | 2014 | 381 | 0.100 |
Why?
|
Integrases | 2 | 2011 | 533 | 0.100 |
Why?
|
DNA Damage | 2 | 2019 | 2423 | 0.100 |
Why?
|
Immunologic Memory | 1 | 2017 | 1348 | 0.090 |
Why?
|
Endodeoxyribonucleases | 1 | 2011 | 162 | 0.090 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2024 | 4438 | 0.090 |
Why?
|
HIV Integrase | 1 | 2011 | 120 | 0.090 |
Why?
|
Mice, Inbred NOD | 3 | 2019 | 1875 | 0.090 |
Why?
|
Leukemia | 2 | 2021 | 1507 | 0.090 |
Why?
|
Mutagenesis, Insertional | 1 | 2011 | 655 | 0.080 |
Why?
|
Mice, SCID | 3 | 2019 | 2715 | 0.080 |
Why?
|
Immunotherapy, Adoptive | 2 | 2015 | 1255 | 0.080 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2011 | 1723 | 0.080 |
Why?
|
Dependovirus | 3 | 2020 | 706 | 0.080 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2011 | 589 | 0.070 |
Why?
|
Genetic Engineering | 2 | 2015 | 952 | 0.070 |
Why?
|
Immunity, Innate | 1 | 2018 | 2956 | 0.070 |
Why?
|
Antibodies, Monoclonal | 1 | 2023 | 9274 | 0.070 |
Why?
|
Cytotoxicity, Immunologic | 2 | 2024 | 1368 | 0.070 |
Why?
|
T-Lymphocyte Subsets | 1 | 2013 | 1837 | 0.060 |
Why?
|
Neoplasm Proteins | 1 | 2017 | 3691 | 0.060 |
Why?
|
Peptide Fragments | 1 | 2017 | 5095 | 0.060 |
Why?
|
Hepatocytes | 1 | 2011 | 1209 | 0.060 |
Why?
|
Humans | 22 | 2024 | 742088 | 0.060 |
Why?
|
Immune Tolerance | 1 | 2011 | 2257 | 0.050 |
Why?
|
Molecular Targeted Therapy | 1 | 2013 | 2723 | 0.050 |
Why?
|
Base Sequence | 3 | 2020 | 12797 | 0.050 |
Why?
|
Interleukin-12 | 1 | 2024 | 579 | 0.050 |
Why?
|
Leukodystrophy, Metachromatic | 1 | 2021 | 42 | 0.050 |
Why?
|
G2 Phase | 1 | 2020 | 139 | 0.050 |
Why?
|
HEK293 Cells | 2 | 2020 | 4200 | 0.050 |
Why?
|
Embryonic Stem Cells | 1 | 2007 | 1294 | 0.050 |
Why?
|
Cytokines | 1 | 2015 | 7317 | 0.050 |
Why?
|
S Phase | 1 | 2020 | 423 | 0.040 |
Why?
|
DNA Repair | 1 | 2007 | 2042 | 0.040 |
Why?
|
Cell Line, Tumor | 4 | 2017 | 16665 | 0.040 |
Why?
|
Exons | 1 | 2024 | 2431 | 0.040 |
Why?
|
Virus Integration | 2 | 2011 | 297 | 0.040 |
Why?
|
K562 Cells | 1 | 2019 | 632 | 0.040 |
Why?
|
Melanoma | 1 | 2015 | 5462 | 0.040 |
Why?
|
Cells, Cultured | 3 | 2017 | 19223 | 0.030 |
Why?
|
Homeodomain Proteins | 1 | 2024 | 2417 | 0.030 |
Why?
|
Cell Line | 2 | 2019 | 15994 | 0.030 |
Why?
|
Leukemia, Myelomonocytic, Acute | 1 | 2013 | 39 | 0.030 |
Why?
|
Genes, Transgenic, Suicide | 1 | 2013 | 29 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2019 | 14554 | 0.030 |
Why?
|
Interleukin-7 | 1 | 2013 | 142 | 0.030 |
Why?
|
Graft vs Host Disease | 2 | 2017 | 2951 | 0.030 |
Why?
|
Viral Proteins | 1 | 2020 | 1899 | 0.030 |
Why?
|
Interleukin-15 | 1 | 2013 | 184 | 0.030 |
Why?
|
Lymphoma | 1 | 2021 | 1873 | 0.030 |
Why?
|
Transplantation, Heterologous | 1 | 2020 | 2382 | 0.030 |
Why?
|
Antigens, CD | 1 | 2022 | 4024 | 0.030 |
Why?
|
Tumor Microenvironment | 1 | 2024 | 3564 | 0.030 |
Why?
|
WT1 Proteins | 1 | 2012 | 178 | 0.020 |
Why?
|
Cell Lineage | 1 | 2020 | 2504 | 0.020 |
Why?
|
Up-Regulation | 1 | 2020 | 4211 | 0.020 |
Why?
|
Jurkat Cells | 1 | 2012 | 742 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2017 | 2077 | 0.020 |
Why?
|
Mutation | 1 | 2014 | 29717 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2013 | 2085 | 0.020 |
Why?
|
Receptors, CCR5 | 1 | 2011 | 497 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2015 | 1835 | 0.020 |
Why?
|
Templates, Genetic | 1 | 2007 | 211 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2011 | 1802 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2013 | 3847 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2020 | 7721 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2017 | 9735 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2013 | 3770 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2011 | 2713 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2013 | 3504 | 0.010 |
Why?
|
Transgenes | 1 | 2007 | 1009 | 0.010 |
Why?
|
Fibroblasts | 1 | 2014 | 4143 | 0.010 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2014 | 1728 | 0.010 |
Why?
|
Binding Sites | 1 | 2011 | 6115 | 0.010 |
Why?
|
Point Mutation | 1 | 2007 | 1624 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2020 | 19862 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2011 | 6382 | 0.010 |
Why?
|
Genetic Loci | 1 | 2011 | 2572 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2011 | 4801 | 0.010 |
Why?
|
Protein Binding | 1 | 2011 | 9387 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2012 | 18112 | 0.010 |
Why?
|
Risk | 1 | 2011 | 9679 | 0.010 |
Why?
|
Male | 1 | 2014 | 349538 | 0.010 |
Why?
|
Female | 3 | 2018 | 379592 | 0.010 |
Why?
|
Concepts
(133)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(16)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_